Allogeneic Cell Therapy
Showing 1 - 25 of >10,000
Diabetic Foot, Diabetic Foot Ulcer, Diabetic Foot Ulcer Neuropathic Trial in Jerusalem (hOMSC200, Placebo)
Recruiting
- Diabetic Foot
- +2 more
- hOMSC200
- Placebo
-
Jerusalem, IsraelShaare Zedek Medical Center
Aug 15, 2023
Multiple System Atrophy, MSA - Multiple System Atrophy Trial in Tel Aviv (hOMSC300, Sham Procedure)
Recruiting
- Multiple System Atrophy
- MSA - Multiple System Atrophy
- hOMSC300
- Sham Procedure
-
Tel Aviv, IsraelTel-Aviv Sourasky Medical Center (Ichilov)
Jan 24, 2023
Stem Cell Transplantation, MDS, Leukemia, Myeloid, Acute Trial in Miami (Mindfulness-based Music Therapy (MBMT), Mindfulness
Not yet recruiting
- Stem Cell Transplantation
- +4 more
- Mindfulness-based Music Therapy (MBMT)
- Mindfulness Meditation (MM)
-
Miami, FloridaUniversity of Miami
Aug 1, 2023
Non Hodgkin's Lymphoma Trial in Beijing (TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T),
Not yet recruiting
- Non Hodgkin's Lymphoma
- TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T)
- +2 more
-
Beijing, China
- +2 more
Aug 23, 2023
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)
Not yet recruiting
- Acute Myeloid Leukemia, in Relapse
- Acute Myeloid Leukemia Refractory
- (no location specified)
Nov 9, 2023
Relapsed/Refractory Large B Cell Lymphoma Trial (biological, drug, genetic)
Not yet recruiting
- Relapsed/Refractory Large B Cell Lymphoma
- ALLO-647
- +3 more
- (no location specified)
Feb 6, 2023
T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)
Recruiting
- T Lymphoblastic Leukemia/Lymphoma
-
Hangzhou, Zhejiang, ChinaThe First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Aug 7, 2023
Multiple Myeloma, Allogeneic Stem Cell Transplantation Trial in Spain (CARTemis-1)
Not yet recruiting
- Multiple Myeloma
- Allogeneic Stem Cell Transplantation
- CARTemis-1
-
Santander, Cantabria, Spain
- +4 more
Aug 1, 2023
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, drug, biological, other)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Apr 10, 2023
Acute Myeloid Leukemia in Children Trial in Saint Louis (CIML NK Cell Infusion, CD3+ T Cell Product Infusion)
Recruiting
- Acute Myeloid Leukemia in Children
- CIML NK Cell Infusion
- CD3+ T Cell Product Infusion
-
Saint Louis, MissouriWashington University School of Medicine
Oct 26, 2022
Heart Failure Trial in Copenhagen Ø (Cardiology Stem Cell Centre Adipose Stem Cell (CSCC_ASC), Placebo)
Completed
- Heart Failure
- Cardiology Stem Cell Centre Adipose Stem Cell (CSCC_ASC)
- Placebo
-
Copenhagen Ø, DenmarkCardiac Catheterization Laboratory 2014, The Heart Centre, Unive
Sep 2, 2022
Systemic Inflammatory Response Syndrome Trial in Madrid (Allogeneic thyTreg 5.000.000, Allogeneic thyTreg 10.000.000)
Recruiting
- Systemic Inflammatory Response Syndrome
- Allogeneic thyTreg 5.000.000
- Allogeneic thyTreg 10.000.000
-
Madrid, SpainHospital General Universitario Gregorio Marañon
Sep 22, 2023
Chronic Kidney Diseases, Diabetes, Type 2, Diabetes, Type 1 Trial in Jacksonville, Rochester (Allogeneic adipose-derived
Recruiting
- Chronic Kidney Diseases
- +4 more
- Allogeneic adipose-derived mesenchymal stem cells (MSC)-Single Infusion
- Allogeneic adipose-derived mesenchymal stem cells (MSC)-Two Infusions
-
Jacksonville, Florida
- +1 more
Nov 9, 2022
Hematological Malignancies, CMV Infection Trial in Belgium (CMV-specific T cells, Standard anti-viral therapy)
Completed
- Hematological Malignancies
- CMV Infection
- CMV-specific T cells
- Standard anti-viral therapy
-
Gent, Oost-Vlaanderen, Belgium
- +7 more
Dec 19, 2022
Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited Trial in Zhengzhou (ThisCART19A, Fludarabine Pill, Cyclophosphamide)
Not yet recruiting
- Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited
- ThisCART19A
- +3 more
-
Zhengzhou, Henan, ChinaHenan cancer hospital
Nov 28, 2022
Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)
Withdrawn
- Multiple Myeloma
- Refractory Multiple Myeloma
- nonmyeloablative allogeneic hematopoietic stem cell transplantation
- +7 more
- (no location specified)
Jan 4, 2023
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, California
- +1 more
Sep 22, 2023
Relapsed/Refractory Multiple Myeloma Trial in New York, Nashville, Salt Lake City (CB-011)
Recruiting
- Relapsed/Refractory Multiple Myeloma
- CB-011
-
New York, New York
- +3 more
Feb 15, 2023
Ischemic Heart Failure, Chronic Heart Failure Trial in Changsha, Nanjing (Human (allogeneic) iPS-cell-derived cardiomyocyte)
Not yet recruiting
- Ischemic Heart Failure
- Chronic Heart Failure
- Human (allogeneic) iPS-cell-derived cardiomyocyte
-
Changsha, Hunan, China
- +1 more
Oct 12, 2022
MDS Trial in Saint Louis (DEC-C, MyeloSeq-HD)
Recruiting
- Myelodysplastic Syndromes
- DEC-C
- MyeloSeq-HD
-
Saint Louis, MissouriWashington University School of Medicine
Jan 18, 2023
Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)
Not yet recruiting
- Chronic Graft Versus Host Disease
- +2 more
- Biopsy
- +11 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 7, 2023
Myeloablative Allogeneic Hematopoietic Cell Transplantation, Intraoral Photobiomodulation Therapy, Oral Mucositis Trial in
Recruiting
- Myeloablative Allogeneic Hematopoietic Cell Transplantation
- +3 more
- THOR LX2.3 with LED Lollipop
-
Boston, MassachusettsBrigham and Women's Hospital
Jun 27, 2022
ARDS, Human Trial (intravenous delivery of allogeneic bone marrow-derived MSCs)
Not yet recruiting
- ARDS, Human
- intravenous delivery of allogeneic bone marrow-derived MSCs
- (no location specified)
Aug 5, 2022
Malignant Solid Tumours Trial in Beijing (Allogeneic ?d T cells)
Recruiting
- Malignant Solid Tumours
- Allogeneic γδ T cells
-
Beijing, Beijing, ChinaBiotherapeutic Department of Chinsese PLA Gereral Hospital
Feb 15, 2022
Nutrition Aspect of Cancer, Stem Cell Transplant Complications Trial (Parenteral nutrition;Enteral nutrition)
Not yet recruiting
- Nutrition Aspect of Cancer
- Stem Cell Transplant Complications
- Parenteral nutrition;Enteral nutrition
- (no location specified)
Oct 18, 2022